Literature DB >> 18663376

Global patterns of variation in allele and haplotype frequencies and linkage disequilibrium across the CYP2E1 gene.

M-Y Lee1, N Mukherjee, A J Pakstis, S Khaliq, A Mohyuddin, S Q Mehdi, W C Speed, J R Kidd, K K Kidd.   

Abstract

Cytochrome P450 2E1, gene symbol CYP2E1, is one of a family of enzymes with a central role in activating and detoxifying xenobiotics and endogenous compounds. Genetic variation at this gene has been reported in different human populations, and some association studies have reported increased risk for cancers and other diseases. To the best of our knowledge, multi-single-nucleotide polymorphism haplotypes and linkage disequilibrium (LD) have not been systematically studied for CYP2E1 in multiple populations. Haplotypes can greatly increase the power both to identify patterns of genetic variation relevant for gene expression as well as to detect disease-related susceptibility mutations. We present frequency and LD data and analyses for 11 polymorphisms and their haplotypes that we have studied on over 2600 individuals from 50 human population samples representing the major geographical regions of the world. The diverse patterns of haplotype variation found in the different populations we have studied show that ethnicity may be an important variable helping to explain inconsistencies that have been reported by association studies. More studies clearly are needed of the variants we have studied, especially those in the 5' region, such as the variable number of tandem repeats, as well as studies of additional polymorphisms known for this gene to establish evidence relating any systematic differences in gene expression that exist to the haplotypes at this gene.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18663376      PMCID: PMC2782390          DOI: 10.1038/tpj.2008.9

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


  34 in total

1.  CYP1A1, CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamous-cell carcinoma of the esophagus.

Authors:  S Morita; M Yano; H Shiozaki; T Tsujinaka; C Ebisui; T Morimoto; M Kishibuti; J Fujita; A Ogawa; M Taniguchi; M Inoue; S Tamura; K Yamazaki; N Kikkawa; S Mizunoya; M Monden
Journal:  Int J Cancer       Date:  1997-04-10       Impact factor: 7.396

2.  THE INTERACTION OF SELECTION AND LINKAGE. II. OPTIMUM MODELS.

Authors:  R C LEWONTIN
Journal:  Genetics       Date:  1964-10       Impact factor: 4.562

3.  A global haplotype analysis of the myotonic dystrophy locus: implications for the evolution of modern humans and for the origin of myotonic dystrophy mutations.

Authors:  S A Tishkoff; A Goldman; F Calafell; W C Speed; A S Deinard; B Bonne-Tamir; J R Kidd; A J Pakstis; T Jenkins; K K Kidd
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

4.  A comparison of linkage disequilibrium measures for fine-scale mapping.

Authors:  B Devlin; N Risch
Journal:  Genomics       Date:  1995-09-20       Impact factor: 5.736

5.  Lack of association of cytochrome P450 2E1 genetic polymorphisms with the risk of human hepatocellular carcinoma.

Authors:  H S Lee; J H Yoon; S Kamimura; K Iwata; H Watanabe; C Y Kim
Journal:  Int J Cancer       Date:  1997-05-29       Impact factor: 7.396

6.  Structural and functional characterization of the 5'-flanking region of the rat and human cytochrome P450 2E1 genes: identification of a polymorphic repeat in the human gene.

Authors:  Y Hu; J Hakkola; M Oscarson; M Ingelman-Sundberg
Journal:  Biochem Biophys Res Commun       Date:  1999-09-24       Impact factor: 3.575

7.  Expression of cytochrome P4502E1 in human liver: assessment by mRNA, genotype and phenotype.

Authors:  H Powell; N R Kitteringham; M Pirmohamed; D A Smith; B K Park
Journal:  Pharmacogenetics       Date:  1998-10

8.  In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians.

Authors:  R B Kim; H Yamazaki; K Chiba; D O'Shea; M Mimura; F P Guengerich; T Ishizaki; T Shimada; G R Wilkinson
Journal:  J Pharmacol Exp Ther       Date:  1996-10       Impact factor: 4.030

9.  A global survey of haplotype frequencies and linkage disequilibrium at the DRD2 locus.

Authors:  K K Kidd; B Morar; C M Castiglione; H Zhao; A J Pakstis; W C Speed; B Bonne-Tamir; R B Lu; D Goldman; C Lee; Y S Nam; D K Grandy; T Jenkins; J R Kidd
Journal:  Hum Genet       Date:  1998-08       Impact factor: 4.132

10.  Relationship between alcoholism and CYP2E1 C/D polymorphism.

Authors:  K Iwahashi; S Ameno; K Ameno; N Okada; H Kinoshita; Y Sakae; K Nakamura; M Watanabe; I Ijiri; S Harada
Journal:  Neuropsychobiology       Date:  1998-11       Impact factor: 2.328

View more
  9 in total

1.  Mini-haplotypes as lineage informative SNPs and ancestry inference SNPs.

Authors:  Andrew J Pakstis; Rixun Fang; Manohar R Furtado; Judith R Kidd; Kenneth K Kidd
Journal:  Eur J Hum Genet       Date:  2012-04-25       Impact factor: 4.246

2.  Leveraging human genetic and adverse outcome pathway (AOP) data to inform susceptibility in human health risk assessment.

Authors:  Holly M Mortensen; John Chamberlin; Bonnie Joubert; Michelle Angrish; Nisha Sipes; Janice S Lee; Susan Y Euling
Journal:  Mamm Genome       Date:  2018-02-23       Impact factor: 3.224

Review 3.  Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective.

Authors:  Gurusamy Umamaheswaran; Dhakchinamoorthi Krishna Kumar; Chandrasekaran Adithan
Journal:  Indian J Med Res       Date:  2014-01       Impact factor: 2.375

4.  Genetic polymorphism of the drug-metabolizing enzyme Cytochrome P4502E1 (CYP2E1) in a healthy Saudi population.

Authors:  Lenah S Binmahfouz; Amina M Bagher
Journal:  Saudi Pharm J       Date:  2021-10-06       Impact factor: 4.330

5.  Global variation in CYP2C8-CYP2C9 functional haplotypes.

Authors:  William C Speed; Soonmo Peter Kang; David P Tuck; Lyndsay N Harris; Kenneth K Kidd
Journal:  Pharmacogenomics J       Date:  2009-04-21       Impact factor: 3.550

6.  Pharmacogenomic assessment of Mexican and Peruvian populations.

Authors:  Sharon Marsh; Cristi R King; Derek J Van Booven; Jane Y Revollo; Robert H Gilman; Howard L McLeod
Journal:  Pharmacogenomics       Date:  2015       Impact factor: 2.533

7.  CYP1A2 polymorphism and theophylline clearance in Korean non-smoking asthmatics.

Authors:  Eun-Young Yim; Hye-Ryun Kang; Jae-Woo Jung; Seong-Wook Sohn; Sang-Heon Cho
Journal:  Asia Pac Allergy       Date:  2013-10-31

8.  Proposed nomenclature for microhaplotypes.

Authors:  Kenneth K Kidd
Journal:  Hum Genomics       Date:  2016-06-17       Impact factor: 4.639

9.  Population genetic difference of pharmacogenomic VIP gene variants in the Lisu population from Yunnan Province.

Authors:  Chan Zhang; Xiaochun Jiang; Wanlu Chen; Qi Li; Fubin Yun; Xin Yang; Run Dai; Yujing Cheng
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.